“Low-grade serous carcinoma is an exciting research area with enormous potential for progress. More than ever before, a growing number of physicians and scientists have become interested in low-grade carcinoma research, and pharmaceuticals are increasingly focused on developing new therapies for this cancer.”

- Dr. David Gershenson, Professor at The University of Texas MD Anderson Cancer Center